We are live on
!
Find out more
DCM
DAFNA Capital Management Portfolio holdings
AUM
$440M
1-Year Est. Return
109.12%
This Fund
S&P 500
This Quarter
Est. Return
+27.83%
1 Year Est. Return
+109.12%
3 Year Est. Return
+239.59%
5 Year Est. Return
+227.89%
10 Year Est. Return
+3,611.91%
AUM
$130M
AUM Growth
+$3.84M
(+3%)
Cap. Flow
-$22.7M
Cap. Flow
% of AUM
-17.42%
Top 10 Holdings %
Top 10 Hldgs %
57.06%
Holding
85
New
22
Increased
8
Reduced
24
Closed
13
Top Buys
| 1 |
AGTC
Applied Genetic Technologies Corporation
AGTC
|
+$2.44M |
| 2 |
ZSPH
ZS PHARMA INC COMS TK (DE)
ZSPH
|
+$1.79M |
| 3 |
OTIC
Otonomy, Inc.
OTIC
|
+$1.71M |
| 4 |
Ascendis Pharma A/S
ASND
|
+$1.7M |
| 5 |
ZGNX
Zogenix, Inc.
ZGNX
|
+$1.21M |
Top Sells
| 1 |
PCYC
PHARMACYCLICS INC
PCYC
|
+$7.59M |
| 2 |
ICPT
Intercept Pharmaceuticals, Inc.
ICPT
|
+$4.31M |
| 3 |
OCRX
Ocera Therapeutics, Inc.
OCRX
|
+$4.04M |
| 4 |
CTIC
CTI BioPharma Corp. (DE) Common Stock
CTIC
|
+$3.36M |
| 5 |
NVDQ
Novadaq Technologies Inc.
NVDQ
|
+$2.4M |
Sector Composition
| 1 | Healthcare | 55.65% |
| 2 | Financials | 0.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PCYC
1
DELISTED
PHARMACYCLICS INC
PCYC
| $18.3M | 14.08% |
71,628
-39,300
| -35% | -$7.59M |
|
2
AtriCure
ATRC
$1.76B
| $13.1M | 10.03% |
637,431
-23,900
| -4% | -$463K |
|
|
ASPX
3
DELISTED
AUSPEX PHARMACEUTICALS INC COM STK (DE)
ASPX
| $12.1M | 9.28% |
120,500
-15,385
| -11% | -$1.02M |
|
|
NXTM
4
DELISTED
NxStage Medical Inc.
NXTM
| $6.34M | 4.87% |
366,554
-17,600
| -5% | -$311K |
|
|
WINT
5
DELISTED
Windtree Therapeutics Inc
WINT
| $5.75M | 4.41% |
344,991
-62,062
| -15% | -$1.22M |
|
|
AERI
6
DELISTED
Aerie Pharmaceuticals
AERI
| $5.02M | 3.86% |
160,242
+27,800
| +21% | +$806K |
|
7
Rigel Pharmaceuticals
RIGL
$765M
| $3.96M | 3.04% |
110,974
+36,067
| +48% | +$989K |
|
8
Insulet
PODD
$11.2B
| $3.54M | 2.71% |
106,018
-3,400
| -3% | -$115K |
|
|
DSCI
9
DELISTED
Derma Sciences, Inc. Common Stock (DE)
DSCI
| $3.17M | 2.43% |
373,918
-10,876
| -3% | -$92.6K |
|
10
Stereotaxis
STXS
$161M
| $2.81M | 2.16% |
1,716,078
-2,641
| -0.2% | -$4.21K |
|
|
MTEM
11
DELISTED
Molecular Templates, Inc.
MTEM
| $2.54M | 1.95% |
3,791
+573
| +18% | +$377K |
|
|
ACHN
12
DELISTED
Achillion Pharmaceuticals
ACHN
| $2.38M | 1.83% |
241,600
+44,100
| +22% | +$551K |
|
13
Protalix BioTherapeutics
PLX
$188M
| $2.19M | 1.68% |
123,079
-15,310
| -11% | -$300K |
|
|
AGTC
14
DELISTED
Applied Genetic Technologies Corporation
AGTC
| $2.19M | 1.68% |
+109,323
| New | +$2.44M |
|
|
MASI
15
DELISTED
Masimo
MASI
| $2.18M | 1.67% |
66,000
-1,500
| -2% | -$43.1K |
|
|
BEAT
16
DELISTED
BioTelemetry, Inc.
BEAT
| $2.08M | 1.6% |
235,645
| – | – |
|
|
OTIC
17
DELISTED
Otonomy, Inc.
OTIC
| $1.77M | 1.36% |
+50,000
| New | +$1.71M |
|
|
CLVS
18
DELISTED
Clovis Oncology, Inc.
CLVS
| $1.74M | 1.33% |
23,400
-500
| -2% | -$35.3K |
|
|
NVDQ
19
DELISTED
Novadaq Technologies Inc.
NVDQ
| $1.65M | 1.27% |
101,841
-161,700
| -61% | -$2.4M |
|
|
ZSPH
20
DELISTED
ZS PHARMA INC COMS TK (DE)
ZSPH
| $1.65M | 1.26% |
+39,100
| New | +$1.79M |
|
|
21
Ascendis Pharma A/S
ASND
$17.4B
| $1.62M | 1.25% |
+93,541
| New | +$1.7M |
|
|
EVFM
22
DELISTED
Evofem Biosciences, Inc. Common Stock
EVFM
| $1.53M | 1.18% |
2,076
+4
| +0.2% | +$2.56K |
|
23
BioCryst Pharmaceuticals
BCRX
$2.4B
| $1.5M | 1.16% |
166,656
| – | – |
|
|
SPNC
24
DELISTED
Spectranetics Corp
SPNC
| $1.38M | 1.06% |
39,812
-2,350
| -6% | -$79.9K |
|
25
Gyre Therapeutics
GYRE
$737M
| $1.38M | 1.06% |
591
| – | – |
|
Similar funds
FGWP
STCG
SCP
CAAM
AWM
HCM
CPW
DWML